Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=A2D230611F1E046DB5C8825168919750;jsessionid=6D8CFF8B7E3AD6622116760881656FC8;jsessionid=329D780699E61FF2644F4E858D8E3810;jsessionid=2C958CF914FB157887FBCB12BCF36573;jsessionid=C82FA57FEB5F24444935625F2CC0B1C0;jsessionid=1E95BF76979C4F52758793557909C6F8;jsessionid=40862B04C0F0786489EB3C417A0E1C15;jsessionid=DAC2727B6C069F5EE9ABEAD8DBC3C775;jsessionid=F0D7C3231ED9CD7A063BFC42E79F4A9F;jsessionid=4A8D6E23DD812431014127EAAD74EE1E;jsessionid=25B43FEAE93C74781D18A289B2B139BE;jsessionid=F13B8402C0AC4291C09B43689A2D67A7;jsessionid=ADB1E2DAD55EC408B5659A14692CA710;jsessionid=95EDC125BD528D69924757B94A83B9F5;jsessionid=E8CAA117FB0D37E93D256E0D8905FEAA;jsessionid=F1E096F7ECD411F80F4F74472BB02624;jsessionid=CB0356E3F884C66608F71E8258E1FC4C;jsessionid=E431A5C60E815E63B2518018F1A42D5A (gene)
Most Correlated Tissues
Task java.util.concurrent.FutureTask@38f2a1c4 rejected from java.util.concurrent.ThreadPoolExecutor@5688fd26[Running, pool size = 100, active threads = 100, queued tasks = 0, completed tasks = 23073828]
Explore Body Atlas Results
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=A2D230611F1E046DB5C8825168919750;jsessionid=6D8CFF8B7E3AD6622116760881656FC8;jsessionid=329D780699E61FF2644F4E858D8E3810;jsessionid=2C958CF914FB157887FBCB12BCF36573;jsessionid=C82FA57FEB5F24444935625F2CC0B1C0;jsessionid=1E95BF76979C4F52758793557909C6F8;jsessionid=40862B04C0F0786489EB3C417A0E1C15;jsessionid=DAC2727B6C069F5EE9ABEAD8DBC3C775;jsessionid=F0D7C3231ED9CD7A063BFC42E79F4A9F;jsessionid=4A8D6E23DD812431014127EAAD74EE1E;jsessionid=25B43FEAE93C74781D18A289B2B139BE;jsessionid=F13B8402C0AC4291C09B43689A2D67A7;jsessionid=ADB1E2DAD55EC408B5659A14692CA710;jsessionid=95EDC125BD528D69924757B94A83B9F5;jsessionid=E8CAA117FB0D37E93D256E0D8905FEAA;jsessionid=F1E096F7ECD411F80F4F74472BB02624;jsessionid=CB0356E3F884C66608F71E8258E1FC4C;jsessionid=E431A5C60E815E63B2518018F1A42D5A
Explore Clinical Trials Results
